imertec launches Crowdcube campaign to fund augmented reality teaching aid for the UK’s health service Tuesday 24 November 2015 PDF Print WHO estimates annual financial losses attributed to healthcare associated infections (HCAIs) of approximately €7 billion in Europe British tech start-up, imertec™, has today launched a crowdfunding campaign on Crowdcube to raise £360,000 for the development and market launch of an innovative teaching aid for healthcare professionals. The wearable device aims to radically improve the way training and guidance is delivered, with the first app designed to help healthcare professionals to adhere to World Health Organisation (WHO)-compliant hand washing techniques. imertec’s interactive Augmented Reality (AR) training application runs on Epson® Moverio BT-200 Smart Glasses. Wearing the glasses, healthcare professionals are guided through an approved seven-step hand washing process, matching their movements to the AR demonstration. By providing an immersive learning experience and recording outcomes for compliance reporting, the imertec team aims to embed correct procedures and ultimately help reduce the number of healthcare-associated infections that are caused by poor hand hygiene. Last year, the National Institute for Health and Care Excellence (NICE) called on the NHS to improve hand hygiene after finding that approximately 300,000 people contract a hospital-acquired infection each year. WHO estimates annual financial losses attributed to healthcare associated infections (HCAIs) of approximately €7 billion in Europe and 16 million extra days in hospital. In the US, the Centre for Disease Control, estimates that the cost could be as high as US$ 30 billion. Studies by WHO reveal that effective hand hygiene could halve the number of HCAIs and their associated costs. By undertaking training using innovative immersive technology, imertec aims to improve long-term compliance with hand hygiene guidance; lower the number of HCAIs; and reduce the use of antibiotics to treat HCAIs. “In spite of routine training on proper hand washing techniques, the NICE report shows that not everyone complies with hand hygiene, resulting in avoidable transmission of infections that require extended hospital stays; an increase in NHS costs and unnecessary distress to patients.” says imertec co-founder, Trevor Heley. “We are at the forefront of developing a new and engaging technology to challenge this growing threat and this presents an exciting and attractive business opportunity to investors.” “We therefore invite interested parties to see for themselves just how the imertec proposition will radically change the way hand hygiene is taught and embedded in to our health system. More information is available via Crowdcube, or by contacting us directly for a demonstration.” The Crowdcube fundraising period lasts for thirty days, with investors being invited to help imertec raise £360,000, in return for equity in the company*. About the imertec application: The imertec app runs on Epson Moverio BT-200 glasses, which allow the wearer to see through both lenses and match their hand movements with the instructional video. The app provides learners with interactive instruction and guidance, on a one to one basis, freeing up training personnel, classroom space and allowing employees to learn at their own pace. The first app module will focus on teaching the NHS/WHO prescribed process for handwashing: the single most important area of infection control, with additional modules being added over the next eighteen months. Using next-generation glasses, imertec will use gesture and object recognition, combined with voice recognition, to introduce truly interactive applications to guide users through a wide range of procedures. imertec will work with distribution partners who already have client relationships with hospitals, GP surgeries, dental surgeries and clinics, and invites interested distributors to contact them to find out more about the full market launch. Epson Moverio BT-200 glasses will be provided to distribution partners for a licence fee, with a recommended price set by imertec. For more information visit www.imertec.com or to access more details regarding investment via the Crowdcube platform visit: www.crowdcube.com/imertec. Follow imertec on Twitter via https://twitter.com/Team_imertec - ends - Notes to Editors: References: Crowdcube campaign: Find details regarding imertec’s Crowdcube campaign here: www.crowdcube.com/imertec. Please #investaware. Investments of this nature carry risks to your capital as well as potential rewards. Please read all Risk Warnings and Disclaimers before deciding to invest: www.crowdcube.com. A video introduction to imertec can also be viewed on YouTube: https://youtu.be/UZn99sZPxEI *Legal Notice Investing involves risk and should be done only as part of a diversified portfolio. Investing equity in start-ups and early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution. Mini-bonds can be unsecured, non-convertible and non-transferable. Crowdcube is targeted exclusively at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. Crowdcube Capital Limited is authorised and regulated by the Financial Conduct Authority (No. 650205) Other Useful Links / References: World Health Organisation, “Five moments for hand hygiene” http://who.int/gpsc/tools/Five_moments/en/ NICE: ‘NHS must renew hygiene efforts to tackle unacceptable and avoidable infection rates,’ 17th April 2015 http://www.nice.org.uk/news/article/nhs-must-renew-hygiene-e... NHS Choices, “NICE highlights how handwashing can save lives,” 17th April 2014: http://www.nhs.uk/news/2014/04April/Pages/NICE-highlights-ho... Infection Control and Hospital Epidemiology 2010; 31(4): 357-364, “Hand hygiene noncompliance and the cost of hospital-acquired methicillin-resistant Staphylococcus aureus infection,” Cummings KL, Anderson DJ, Kaye KS, published 25/08/2010. NHS Institute for Innovation and Improvement: Protection from Infection http://www.institute.nhs.uk/building_capability/general/prot... http://www.institute.nhs.uk/building_capability/general/prot... ‘Review on Antimicrobial Resistance. Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations. 2014.’ http://www.his.org.uk/files/4514/1829/6668/AMR_Review_Paper_... Study by the Department of learning, Informatics, Management and Ethics, Karolinska Institutet, Stockholm and Faculty of Education, Hubei University, China Evidence from a study conducted in July 2014 based on a review of over 200 academic studies concluded, “AR is in the early stages of application within healthcare education but it has enormous potential for promoting learning in healthcare”. http://www.ncbi.nlm.nih.gov/pubmed/25071992 Target market UK: GP surgeries; NHS hospitals; private hospitals; and NHS clinics and ambulance trusts. ## About imertec: imertec™ is the brand name of Immersive Technologies Limited, a UK-based company dedicated to developing augmented interactive reality applications, which are used to train and guide employees in standard procedures for healthcare and safety critical environments. The company was founded in 2014 by a team of entrepreneurs with in-depth experience in IT, technology and infection control. Working through distribution partners, imertec aims to provide UK healthcare providers with a range of immersive applications that radically improve the training and guidance delivered to healthcare professionals, resulting in more widespread compliance with approved procedures that benefit patient health and safety. www.imertec.com https://twitter.com/Team_imertec Editor’s Contacts: Peppa Sheridan // Josie Herbert Telephone: 01787 313822 email@example.com // firstname.lastname@example.org ## *Legal Notice Investing involves risk and should be done only as part of a diversified portfolio. Investing equity in start-ups and early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution. Mini-bonds can be unsecured, non-convertible and non-transferable. Crowdcube is targeted exclusively at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. Crowdcube Capital Limited is authorised and regulated by the Financial Conduct Authority (No. 650205) This press release was distributed by ResponseSource Press Release Wire on behalf of Peptalk Communications in the following categories: Health, Consumer Technology, Business & Finance, for more information visit http://pressreleasewire.responsesource.com/about.